Literature DB >> 12935892

Silymarin inhibits TNF-alpha-induced expression of adhesion molecules in human umbilical vein endothelial cells.

Jong Soon Kang1, Song-Kyu Park, Kyu-Hwan Yang, Hwan Mook Kim.   

Abstract

Silymarin is known to have an anti-atherosclerotic activity, but the mechanism responsible for it remains unclear. Here, we demonstrate a possible mechanism involved in the anti-atherosclerotic activity of silymarin. Silymarin inhibited THP-1 cell adhesion to human umbilical vein endothelial cells (HUVECs). Silymarin also suppressed the TNF-alpha-induced protein and mRNA expression of adhesion molecules, such as VCAM-1, ICAM-1 and E-selectin, in HUVECs. Moreover, silymarin suppressed the TNF-alpha-induced DNA binding of NF-kappaB/Rel in HUVECs. Taken together, these results demonstrate that silymarin exerts an anti-atherosclerotic activity, at least in part, by inhibiting the expression of adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12935892     DOI: 10.1016/s0014-5793(03)00827-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Silymarin and epithelial cancer chemoprevention: how close we are to bedside?

Authors:  Manjinder Kaur; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-15       Impact factor: 4.219

2.  MCP-induced protein 1 suppresses TNFalpha-induced VCAM-1 expression in human endothelial cells.

Authors:  Yongfen Qi; Jian Liang; Zhi-Gang She; Yan Cai; Jing Wang; Tianhua Lei; William B Stallcup; Mingui Fu
Journal:  FEBS Lett       Date:  2010-05-24       Impact factor: 4.124

3.  Vascular relaxation induced by Eucommiae Ulmoides Oliv. and its compounds Oroxylin A and wogonin: implications on their cytoprotection action.

Authors:  Mary Akinyi; Xiu Mei Gao; Yu Hong Li; Bing Yao Wang; Er Wei Liu; Li Juan Chai; Abdulai JawoBah; Guan Wei Fan
Journal:  Int J Clin Exp Med       Date:  2014-10-15

4.  Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway.

Authors:  Jun Yang; Congxin Huang; Jian Yang; Hong Jiang; Jiawang Ding
Journal:  Mol Cell Biochem       Date:  2010-08-17       Impact factor: 3.396

5.  Cl- channels are expressed in human normal monocytes: a functional role in migration, adhesion and volume change.

Authors:  M-J Kim; G Cheng; D K Agrawal
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

6.  Piper sarmentosum inhibits ICAM-1 and Nox4 gene expression in oxidative stress-induced human umbilical vein endothelial cells.

Authors:  Azizah Ugusman; Zaiton Zakaria; Chua Kien Hui; Nor Anita Megat Mohd Nordin
Journal:  BMC Complement Altern Med       Date:  2011-04-16       Impact factor: 3.659

7.  The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.

Authors:  Jana Pourová; Lenka Applová; Kateřina Macáková; Marie Vopršalová; Thomas Migkos; Roger Bentanachs; David Biedermann; Lucie Petrásková; Václav Tvrdý; Marcel Hrubša; Jana Karlíčková; Vladimír Křen; Kateřina Valentová; Přemysl Mladěnka
Journal:  Nutrients       Date:  2019-09-24       Impact factor: 5.717

8.  Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells.

Authors:  Jagan Mohan Kaipa; Vytaute Starkuviene; Holger Erfle; Roland Eils; Evgeny Gladilin
Journal:  PeerJ       Date:  2020-12-16       Impact factor: 2.984

9.  Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway.

Authors:  Eun Jeong Kim; Min Young Lee; Young Jin Jeon
Journal:  Korean J Physiol Pharmacol       Date:  2015-04-30       Impact factor: 2.016

10.  Silibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells.

Authors:  Yi-Hao Chen; Ching-Long Chen; Chang-Min Liang; Jy-Been Liang; Ming-Cheng Tai; Yun-Hsiang Chang; Da-Wen Lu; Jiann-Torng Chen
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.